A top human resources officer at Eli Lilly and Co.’s factory in New Jersey claims the drugmaker fired her in retaliation for investigating employee complaints about drug manufacturing problems and for refusing to drop the matters.
Amrit Mula, who was terminated in March 2019 as associate director of employee relations, filed suit this month in U.S. District Court in Trenton, New Jersey.
In a statement to IBJ, Lilly denied the allegations and said it is “deeply committed” to the safety and quality of its products.
Mula is bringing her complaint as a whistleblower and is accusing the Indianapolis-based drugmaker of retaliating against her in violation of New Jersey’s Conscientious Employee Protection Act.
That law prohibits employers from taking retaliatory personnel action against an employee who refuses to participate in any activity that the employee believes is in violation of the law.
Mula said that for nearly a year, beginning in August 2018, she witnessed and reported Lilly employees failing to adhere to good manufacturing practices, failing to comply with federally-mandated standard operating procedures, failing to report batch contaminations, improperly disposing of caustic substances into waterways and falsifying quality assurance testing.
The lawsuit says many of the issues were primarily related to the sale of Trulicity, Lilly’s blockbuster medicine for Type 2 diabetes. Trulicity is Lilly’s top-selling product, ringing up sales last year of $6.47 billion,...
SHANGHAI, April 9 (Reuters) – China has removed all medical advertisements on national TV channels containing false claims as of the end of March, the country’s National Radio and Television Admini...